Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Schisandrin B
Cat. No.:
OB0225LY-0306
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Schisandrin B is a compound with antioxidant effect on rodent liver and heart.
Synonym:
gamma-Schisandrin; 61281-37-6; 3,4,5,19-Tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene; S(-) Schisandrin B; Schizandrin-B; 1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxole
CAS No.:
61281-37-6
Compound CID:
108130
Formula:
C23H28O6
Formula Weight:
400.46
Specification
Relative Density:
1.148 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Schisandrin B can be used in studies of liver protection or play an important role in mitigating the effects of oxidative stress.
Library Information
Targets:
Reactive oxygen species; ATM/ATR; Autophagy
Pathways:
Autophagy; DNA damage/DNA repair; NF-κB; Metabolism; PI3K/Akt/mTOR signaling; Immunology/Inflammation
Plate Number:
AOCL-4
Plate Location:
h8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 137.34 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
10 mg/mL; 24.97 mM
